TEL AVIV STOCK EXCHANGE · TEVA
-1.22% · -$0.4100 · Vol 4.7M
Market closed · last close 4:00 PM ET · price as of 19:00:00 ET
Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd

Pharmaceuticals
$33.21

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is TEVA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Teva Pharmaceutical Industries Ltd
PHARMACEUTICAL PREPARATIONS
Listed since
1982
Employees
33K
Country
IL

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$33.47
Day high
$34.14
Day low
$32.96
Previous close
$33.62
52W high
$34.14
-2.72% from high
52W low
$32.96
21% of range
Market cap
$39.1B
Shares out
1.2B
Volume
4.7M
VWAP
$33.35
Price history computed in-house
SMA 50 Not reported · Not reported
SMA 200 Not reported · Not reported
52W position 21%
Veridion warehouse edge

Warehouse intelligence for TEVA.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

TEVA insider activity

Teva Pharmaceutical Industries Ltd

Score
Coverage building
Pressure
Net selling
Filings
53
Buys / sells
4 / 49
Net value
-$92.8M
Insiders
13
Named filers
SM
Shields Matthew
Insider
Leadership
KS
Kalif Eliyahu Sharon
Insider
Leadership
FD
Francis Richard D
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$92.8M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-222026-06-18Shields MatthewInsidersell$32.199,989Not reported$322KSEC Form 4
2026-06-162026-06-11Kalif Eliyahu SharonInsidersell$34.10106,56365,621$3.6MSEC Form 4
2026-06-082026-06-05Francis Richard DInsidersell$34.356,1531,177,529$211KSEC Form 4
2026-06-042026-06-03Shields MatthewInsidersell$32.8716,1959,989$532KSEC Form 4
2026-05-182026-05-14Lippman EvanInsidersell$35.5835,91244,191$1.3MSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 48 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

TEVA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for TEVA in this window.
Lobbying spend

TEVA lobbying filings, year to date.

Registered lobbying filings matched to Teva Pharmaceutical Industries Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for TEVA in this window.
Latest news · TEVA
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for TEVA.
Options
Sovereign unlock shows live options positioning for TEVA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.